Atossa therapeutics, inc. (ATOS)
CashFlow / Yearly
Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss

-17,239

-11,404

-8,122

-6,368

-15,760

-

-

-

-3,442

Adjustments to reconcile net loss to net cash used in operating activities
Net loss

-

-

-

-

-

-14,657

-10,784

-5,079

-

Net loss from discontinued operations

-

-

-

-

-3,002

-2,487

-

-

-

Compensation cost for stock options granted

7,102

1,053

786

876

840

-

-

-

-

Disposal of assets

-5

-

-17

-163

-

-

-

-

-

Common shares issued for services

-

-

-

-

-

-

178

0

0

Change in stock-based compensation liability

-

-

-

-

-

556

1,443

121

140

Loss on reduction on obsolete inventory

-

-

-

-

-

-

149

29

92

Impairment of long-lived assets

-

-

-

-

-

2,352

158

0

-

Loan initiation fee accrued for notes payable

-

-

-

-

-

-

-

0

0

Depreciation and amortization

52

44

128

303

272

480

472

130

15

Change in fair value of stock-based compensation liability

-

-

461

718

0

-

-

-

-

Change in fair value of common stock warrants

-

-

280

-

-

-

-

-

-

Warrant financing expense

-

-

192

-

-

-

-

-

-

Change in fair value of stock-based compensation liability

1,741

1,410

-

-

-

-

-

-

-

Contingent loss

-

-

-

-

-

-

-

0

-

Bad debt expenses

-

-

-

-

-

-

354

0

-

Changes in operating assets and liabilities:
Accounts receivable

-

-

-

-

-

-1

352

140

-1

Change in restricted cash

-

-

-

-

275

0

-

-

-

Inventory

-

-

-

-

-9

9

149

29

-92

Prepaid expenses

352

258

79

-21

-0

-1

57

91

-31

Research and development tax rebate receivable

221

159

358

-

-

-

-

-

-

Restricted cash

-

-

-

-220

-

-

-

-

-

Other assets

-4

-74

80

-144

110

0

-

-

-

Security deposits

-

-

-

-

-28

-11

0

-29

-2

Accounts payable

-60

18

80

-560

301

264

-58

3

64

Decrease (Increase) in accrued payroll

-

-

-

-

-

-

-

-33

-278

Deferred rent

-

-

-

-

-2

-45

48

0

-

Product recall liabilities

-

-

-

-

-

-211

211

-

-

Accrued expenses

-99

86

73

-446

209

41

-704

1,198

43

Payroll liabilities

-35

150

14

-389

199

379

268

-

-

Other current liabilities

-27

24

9

-58

21

-91

-8

19

-

Net cash used in operating activities

-

-

-

-

-11,319

-8,461

-8,830

-3,899

-

Net cash used in discontinued operating activities

-

-

-

-

-2,633

-2,093

-

-

-

Net cash used in operating activities

-9,128

-8,961

-6,593

-5,374

-13,953

-10,555

-

-

-3,492

CASH FLOWS FROM INVESTING ACTIVITY
Purchase of furniture and equipment

7

110

-

-

-

-

-

-

-

Purchase of furniture, fixtures and equipment

-

-

-

9

130

-158

244

104

86

Purchases of intangible assets

-

-

-

-

-

163

245

30

50

Net cash used in continuing investing activities

-

-

-

-

-130

-4

-489

-134

-

Net cash used in discontinued investing activities

-

-

-

-

-157

-338

-

-

-

Net cash used in investing activities

-7

-110

-

-9

-288

-343

-

-

-136

CASH FLOWS FROM FINANCING ACTIVITY
Proceeds from issuance of Series B convertible preferred stock and warrants, net of issuance costs

-

12,290

-

-

-

-

-

-

-

Proceeds from issuance of Class A and Class B Units, net of issuance costs

-

-

3,871

-

-

-

-

-

-

Proceeds from exercise of warrants

11,336

-

749

-

-

-

-

-

-

Net proceeds from issuance of common stock and warrants

-

-

-

4,695

9,456

13,155

-

-

-

Payments on capital lease obligations

-

-

-

-

-

98

0

-

-

Proceeds from issuance of common stock and warrants, net of issuance costs

-

-

6,162

-

-

-

13,936

3,854

5,713

Repayments from bank line of credit

-

-

-

-

-

-

-

-1,000

1,000

Repayments of loans from related parties

-

-

-

-

-

-

-

-5

-183

Cash released from commercial line of credit

-

-

-

-

-

-

-

1,000

-1,000

Net cash provided by financing activities

-

-

-

-

9,456

13,057

13,936

3,848

-

Net cash provided by financing activities

11,336

12,290

10,783

4,695

-

-

-

-

5,529

NET (DECREASE) INCREASE IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH

2,200

3,218

4,189

-

-

-

-

-

-

SUPPLEMENTAL DISCLOSURES
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS

-

-

-

-687

-4,784

2,158

4,616

-185

1,900

Interest Paid

-

-

0

-

-

-

-

-

-

Interest paid

-

-

-

-

0

15

0

14

17

Income taxes paid

-

-

-

-

-

-

-

0

0

NONCASH INVESTING AND FINANCING ACTIVITIES
Reclassification of stock-based liability awards to equity upon cancellation

3,151

-

-

-

-

-

-

-

-

Amortization of commitment shares

-

72

79

-

-

-

-

-

-

Reclassification of furniture and equipment to prepaid expenses

-

-

-

-

-

15

0

-

-

Furniture and fixtures acquired through capital lease

-

-

-

-

-

206

0

-

-

Amortization of commitment shares issued for shares distributed for capital contribution

-

-

-

42

355

0

-

-

-

Common stock and warrants issued for asset purchase

-

-

-

-

-

-

-

4,674

0

Options issued for previously accrued director compensation

-

-

-

-

-

-

-

45

0

Commitment shares distributed for capital contribution

-

-

-

-

-

-

-

0

-

Amortization of deferred financing costs

-

-

-

-

-

-

-

0

-

Common stock issued as commitment fee under stock purchase agreement

-

-

-

-

-

-

2,387

-

-